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Abstract
Intact, enveloped coronavirus particles vary widely in size and contour, and are thus
refractory to study by traditional structural means such as X-ray crystallography. Electron
microscopy (EM) overcomes some problems associated with particle variability and has
been an important tool for investigating coronavirus ultrastructure. However, EM sample
preparation requires that the specimen be dried onto a carbon support film before imaging,
collapsing internal particle structure in the case of coronaviruses. Moreover, conventional
EM achieves image contrast by immersing the specimen briefly in heavy-metal-containing
stain, which reveals some features while obscuring others. Electron cryomicroscopy (cryo-
EM) instead employs a porous support film, to which the specimen is adsorbed and flash-
frozen. Specimens preserved in vitreous ice over holes in the support film can then be
imaged without additional staining. Cryo-EM, coupled with single-particle image analysis
techniques, makes it possible to examine the size, structure and arrangement of coronavirus
structural components in fully hydrated, native virions. Two virus purification procedures
are described.
Key words: coronavirus; cryo-EM; virus purification; density gradient centri-
fugation
1. Introduction
The success of electron cryomicroscopy (cryo-EM) is highly dependent on
the quality of the prepared sample. Experience has shown that in order to be use-
ful cryo-EM virion preparations should contain approximately 1010 infectious
particles per milliliter in a relatively pure suspension. This requires at minimum
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a 100-fold concentration step, since coronavirus growth seldom surpasses 108
PFU/ml. Moreover, the coronavirus envelope and the protein-mediated con-
nections between the membrane and the ribonucleoprotein are sensitive to
mechanical and osmotic disruption. The viral spike proteins (S) are sensitive
to ectodomain shearing and, if cleaved, to shedding of the amino-terminal S1
subunit. The method of concentration and purification described here is designed
to minimize these disruptive forces and has been used successfully with several
coronaviruses and other enveloped viruses.
Sample adsorption is sensitive to viscosity, and both the alternative serum-
free purification protocol and the sample loading protocol provide potential
solutions for high-viscosity preparations. These protocols are designed to assist
the investigator in preparing virus samples for cryo-EM. From this point,
microscopy and image analysis techniques will vary with the type of instru-
ment and the nature of the investigation. It is hoped that these techniques will
facilitate further examination of coronavirus, torovirus, arterivirus, and ronivirus
supramolecular architecture.
2. Materials
2.1. Virus Purification and Concentration
1. Dulbecco’s Modified Eagle’s Medium supplemented with 10% fetal bovine serum,
antibiotics, 10 mM HEPES buffer, pH 7.
2. Precipitation reagents: polyethylene glycol-8000, white flake type (PEG-8000
Ultra for Molecular Biology, available from Fluka) and NaCl, crystalline, high
quality.
3. HEPES-saline: 9 g NaCl (0.9% final), 10 ml of 1 M HEPES, 990 ml purified water,
pH adjusted to 7.0, vacuum-sterilized through a 0.2-m pore size membrane.
4. 3X HEPES-saline: 27 g NaCl, 30 ml of 1 M HEPES, 930 ml purified water, pH
adjusted to 7.0.
5. 50% (w/w) sucrose: 50 g sucrose, 50 g HEPES-saline, vacuum-sterilized through
a 0.2-m pore size membrane. Dilute with HEPES-saline to prepare 10, 20, and
30% sucrose solutions.
6. 25% neutral buffered formalin: 10 ml of formalin (37–40% formaldehyde), 5 ml
of 3X concentrated HEPES-saline.
7. Centrifuges and rotors: A low-speed centrifuge and rotor with a capacity of ≥1
liter (Sorvall GSA, e.g.), and a high-speed centrifuge and rotor with a total capac-
ity ≥100 ml (Beckman SW28, e.g.).
2.2. Serum-Free Virus Purification and Concentration
1. Virus production serum-free medium (VP-SFM; Gibco/Invitrogen) supplemented
with antibiotics and glutamine.
2. All other reagents and equipment as in Section 2.1.
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Fig. 1. Cryo-EM of feline coronavirus (FCoV). Arrays of holes containing vitrified
FCoV particles can be seen at left (A), along with a close-up image of a single hole (B).
The viral envelope, spikes, and internal components are visible at higher magnification
(C) and (D). Automated image collection was performed using Leginon.
2.3. Quality Control EM
1. Formvar/carbon coated 200-mesh or 300-mesh EM grids (available from Ted
Pella).
2. Plasma glow discharge unit (available from Emitech).
3. Negative stain: 2 g uranyl acetate (available from Electron Microscopy Sciences),
100 ml purified water, filtered through a 0.2-m membrane, stored in a brown
glass bottle away from light.
4. HEPES-buffered saline (Section 2.1, step 5).
5. Parafilm M (American Can Company).
6. Fine forceps for EM grid manipulation (available from Ted Pella).
7. Filter paper (Whatman 3 M).
2.4. Sample Loading and Grid Freezing
1. Holey carbon grids (Quantifoil holey film with circular holes; Quantifoil Micro
Tools) (Fig. 1).
2. Cryogenic reagents: Liquid nitrogen and an ethane gas cylinder fitted with a flow
regulator and a fine nozzle.
3. Ethane plunge device: large liquid nitrogen reservoir, smaller ethane liquefaction
chamber made from a thermally conductive material, and a drop-release speci-
men holder (available as a set from Electron Microscopy Sciences).
3. Methods
As the quality of the virus preparation is the most important component of
the cryo-EM technique, two purification protocols are listed below. Either can
yield cryo-EM-quality coronavirus, but the method in Section 3.1 is generally
preferred because the serum proteins function as a “carrier” during the PEG
precipitation step. Serum-free purification (Section 3.2) can be used when virus
preparations tend to produce overly viscous purified virion solutions. For best
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results, the purification process should be completed in 1 day, and the virus
loaded onto holey grids no later than 24 h after purification.
3.1. Virus Purification and Concentration
1. This method is suitable for most coronaviruses that grow well in cultured cells
and has been used successfully with SARS-CoV, FcoV, and MHV (1) in addi-
tion to several types of arenavirus (B. N., unpublished data). For the purpose
of this protocol, it is assumed that SARS-CoV is being prepared on Vero-E6
cells.
2. Culture Vero-E6 cells in DMEM to approximately 70–90% confluency (see
Note 1).
3. Inoculate with SARS-CoV at a multiplicity of approximately 3 PFU/cell.
4. Remove the inoculum after 1 h and replace it with fresh medium.
5. Remove and discard the culture medium 24 h after inoculation. Replace it with
fresh DMEM (see Note 2).
6. Collect the cell culture supernatant 48 h after inoculation. Store a small sample
for plaque assay titration (see Note 3).
7. Transfer the supernatant to centrifuge bottles with screw caps, noting the total
volume. Pellet cellular debris at 10,000 × g, 4◦C for 20 min. It is best to use a
high-capacity rotor at this stage to minimize preparation time.
8. During the centrifugation, prepare fresh screw-cap centrifuge bottles containing
10 g of dry PEG-8000 and 2.2 g of NaCl per 100 ml of culture medium to be
added. Alternatively, prepare a large conical flask with sufficient PEG-8000 and
NaCl to bring the entire volume of virus-containing medium to a final concen-
tration of 10% PEG-8000, 2.2% NaCl. Chill HEPES-saline and neutral-buffered
formalin on ice for later use (see Note 4).
9. After centrifugation (step 6), an off-white or yellow pellet of cell debris will
be visible. Decant the supernatant into the centrifuge bottles or conical flask
prepared earlier with PEG and NaCl.
10. Swirl the mixture gently until the additives are fully dissolved. Add a clean stir
bar and incubate at 4◦C for a further 30 min with gentle stirring.
11. Transfer the solution to centrifuge bottles, if you have not done so already Collect
the PEG-precipitated protein fraction by centrifugation for 30 min at approxi-
mately 10,000 × g.
12. During the centrifugation, prepare three-step 10% - 20% - 30% sucrose gradients
in tubes appropriate to the high-speed centrifuge rotor. If using the Beckman
SW-28 rotor, use ∼8 ml for each step, leaving ∼10 ml for sample loading and
balancing (see Note 5).
13. Decant and discard supernatants immediately to minimize sample loss. A large
opaque white pellet should be present in each of the flasks following centrifuga-
tion. Swirl the pellet in cold HEPES-saline until dissolved. Avoid using a pipette
at this step, if possible. It is critical that the PEG pellets be completely resus-
pended before proceeding to the next step (see Note 6).
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14. Overlay the PEG-protein solution carefully onto the sucrose gradients. Balance
with remaining sample or additional HEPES-saline. Pellet the virions through
the sucrose cushions by centrifugation at 100,000 × g for 90 min at 4◦C.
15. Decant and discard supernatants immediately. Invert the empty tubes on an
absorbent surface for 5 min and tap gently to wick away any remaining sucrose
solution. Resuspend the virion pellet in as small a volume of HEPES-saline as
possible (typically 100–200 l). Do not use a pipette to resuspend the virus, as
this may shear spikes and damage fragile viral envelopes (see Note 7).
16. When the pellet has been resuspended, the HEPES-saline will turn somewhat
milky in color. Use a P-1000 pipette tip with the pointed end removed to gently
transfer the virus suspension to a cryovial. Discard any insoluble material. Set
aside a small sample for diagnostic purposes.
17. At this stage, the virus should be monodisperse, and can be inactivated if desired.
Treatment with a 1% final concentration of ice-cold neutral buffered formalin,
2-propiolactone treatment, or gamma-irradiation should all yield intact, inacti-
vated EM-quality particles. Samples for cryo-EM may be stored at 4◦C for up to
24 h (see Note 8).
3.2. Serum-Free Virus Purification and Concentration
1. This alternative method is suitable for purification of viruses that grow to lower
titers. Serum-free culture and preparation can also be used to remedy solutions
that fail for cryo-EM owing to high viscosity, nonviral protein contamination,
or large amounts of insoluble material. Percentage recovery will often be lower
than with the protocol described in Section 3.1 (see Note 9).
2. Perform steps 2 to 11 in Section 3.1, substituting VP-SFM for DMEM starting
at the time of inoculation.
3. The PEG-protein pellets should be white and may be quite small. Decant and
discard the supernatants immediately. Resuspend by swirling gently in 10 ml
HEPES-saline (see Note 10).
4. Perform steps 12 to 15 in Section 3.1. The final translucent pellet may be small
and quite difficult to see.
3.3. Quality Control
1. The relative infectivity of the final preparation should be directly assessed by
plaque assay or similar means as a retrospective measure of quality. However, the
decision to freeze grids for cryo-EM must be taken immediately. The quickest
way to assess sample quality is by standard transmission EM of a negatively
stained sample. Ideal samples for cryo-EM should contain a high density of viri-
ons with intact spikes and little nonviral material. This protocol describes how to
prepare a negatively stained coronavirus specimen for transmission EM.
2. Plasma glow discharge several formvar/carbon-coated EM grids prior to use to
make the support surface more hydrophilic (see Note 11).
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3. Trace several lines on a piece of parafilm M with the dull end of a pair of
forceps to create channels for droplets of negative stain and wash buffers. On
the parafilm, place one ∼20 l droplet of 2% uranyl acetate and up to three
droplets of HEPES-saline along the grid. The number of HEPES-saline washes
will depend on the viscosity of the virus sample being imaged (see Note 12).
4. Place 3–5 l of the viral sample on each grid, and adsorb for 5 min.
5. Float each grid on each droplet of HEPES-saline for 30 sec. Do not reuse buffer
or stain droplets to avoid sample contamination.
6. Float each grid on a uranyl acetate droplet for 1 min.
7. Touch the edge of the grid to the filter paper several times to remove excess stain
(see Note 13).
8. Samples should be visualized immediately, but can be stored for longer periods
under a vacuum.
3.4. Sample Loading and Grid Freezing
1. This procedure describes a protocol for vitrifying coronavirus specimens.
2. Plasma glow discharge holey carbon grids before use.
3. Fill the outer coolant reservoir of the vitrification apparatus with liquid nitrogen.
This will be used to cool ethane to liquid form, and ultimately a semisolid “slush”
that will be used to cryopreserve the virus sample.
4. Wait until the temperature of the inner cooling chamber has stabilized, and
the liquid nitrogen is no longer boiling. Dispense ethane into the inner cooling
chamber. Wear protective clothing and eye protection at this stage, since ethane
splatter can be dangerous. Fill the ethane chamber without allowing any liquid
nitrogen to splash into the inner chamber. Stir occasionally until the consistency
of the liquid ethane changes as it begins to freeze. If the ethane freezes at any
point, liquefy it by adding fresh ethane.
5. Center a pair of EM forceps in the plunge device over the inner ethane chamber.
Check that the grid will be plunged well below the level of the ethane slush.
Adjust the level of ethane if necessary.
6. Pick up a holey carbon grid by the edge using the forceps and slot the forceps
into the plunge device.
7. Adsorb 3–5 l of sample onto the carbon-coated (dull) side of the grid.
8. Blot the edge of the grid against the filter paper to remove excess volume (see
Note 14).
9. Immediately plunge the grid into the ethane slush (see Note 15).
10. Detach the forceps, still holding onto the grid below the surface of the ethane.
Avoid touching the walls of the ethane chamber.
11. Quickly transfer the sample from the ethane to the outer liquid nitrogen reservoir.
12. Place the grid into a grid box while still under the liquid nitrogen. Avoid bumping
the grid on the walls of the liquid nitrogen reservoir. The grid must be stored and
handled under liquid nitrogen from this point forward to remain vitrified.
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4. Notes
1. Plan to prepare at least ∼1010 PFU of SARS-CoV. Assuming an average SARS-
CoV titer of ∼107 PFU/ml, 1 liter or more of infectious cell culture medium
will be needed. One-well plates (available from Nalgene) can be a cost- and
space-effective alternative to standard tissue culture flasks for large-scale virus
preparation.
2. Early time points containing little virus can be discarded. Purification efficiency
is strongly dependent on concentration.
3. Virus can be collected at 2- h intervals beginning 48 h after inoculation to
increase the final yield. However, for best results, each virus sample should be
processed immediately, rather than collected and stored.
4. For viruses with cleaved spike proteins, such as MHV, the amount of NaCl added
should be reduced to 1 g/100 ml to minimize damage to the spikes.
5. Alternatively, virus can be banded at the interface of a 30–50% two-step sucrose
gradient.
6. In general, rapid resuspension, cold temperature, and the minimization of mechan-
ical stress will all improve the quality of the preparation. Soluble proteins con-
tained in the pellet may alter the color to a yellowish hue.
7. The translucent virion pellet may be difficult to see. Whether or not the pellet is
visible, attempt to resuspend immediately. If a pellet is present, the viscosity of
the added HEPES-saline will increase noticeably upon resuspension.
8. Inactivation techniques should be validated beforehand. Both formaldehyde and
2-propiolactone can lose effectiveness over time. Tris buffers will react with
formaldehyde, and should be avoided. HEPES buffer is therefore recommended
for use throughout the purification process.
9. The growth of SARS-CoV, FcoV, and MHV is not affected by short-term treat-
ment with VP-SFM as outlined here. However, cells do grow more slowly in
VP-SFM as compared to DMEM, and thus VP-SFM is not recommended for the
initial cell culture step.
10. If left in contact with the supernatant, serum-free PEG pellets will resuspended
much more quickly than serum-containing pellets, and the sample may be lost.
11. Grids that continually sink in the saline or stain droplets likely have suffered
extensive damage to the support surface and should not be used.
12. The purpose of glow discharge treatment is to impart a charge to the carbon-
coated side of the grid, which can otherwise be quite hydrophobic. Therefore,
glow discharge grids with the carbon side, which will appear slightly dull, facing
upward.
13. The effects of the electron beam on large amounts of residual stain can cause
a “blowout” of the carbon/formvar support surface. It is therefore important to
remove all excess stain before visualization.
14. The vitrified ice supporting the specimen must be very thin (∼1 m or less) to
permit clear imaging.
15. Sample blotting is unfortunately an inexact process. The thickness of the sample
ice can be adjusted by altering blotting time, which typically ranges from 0.5 to
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about 15 sec. Ice thickness and quality will have to be assessed by EM (Fig. 1),
so it is recommended that several grids be prepared at once using different blot
times.
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